期刊文献+

尿毒症患者淋巴细胞亚群改变的研究 被引量:7

Study of the lymphocyte subset changes in uremic patients
下载PDF
导出
摘要 目的了解尿毒症患者淋巴细胞亚群的改变。方法采用血液细胞计数仪对血液细胞进行分类与计数;使用单激光三色流式细胞仪,分析带荧光标记单克隆抗体染色的淋巴细胞及其亚群。结果①血常规计数表明:尿毒症患者存在淋巴细胞减少症(P<0.005),中性粒细胞百分比高于正常对照组(P<0.005);②淋巴细胞亚群分析提示:尿毒症患者CD3+、CD4+、CD8+细胞百分数以及CD4/CD8比值,与正常对照组相比差异无显著性(P>0.05);NK细胞百分数明显增高(P<0.005),透析组CD8+细胞数较未透析组增加[(27.45±7.26)%Vs(20.33±7.01)%,P=0.042],单核细胞数高于正常对照组[(75.6±9.68)%Vs(63.98±12.82)%P=0.039];B淋巴细胞数低于正常对照组[(4.33±1.69)%Vs(9.49±3.30)%P=0.001];③尿毒症患者表现为Th2细胞优势(P<0.05),Th1/Th2比值显著降低(P<0.05),长期透析后上述表现无改善。结论尿毒症患者T细胞亚群表现为Th2优势,透析患者存在B淋巴细胞减少,淋巴细胞亚群的这些改变可能参与了血液透析患者免疫功能下降的发病机理。 Objective To investigate the lymphocyte subset changes in uremic patients. Methods Peripheral blood cells of uremic patients and normal corntrols were differentially counted with automated blood cell counter. Lymphocyte subsets stained with monoclonal antibodys labeled with fluorescent against CD3, CD4, CDS, CD14, CD16, CD19, CD56, IFN-γ and IL4 were examined by three-color flow-cytometry. Results Lymphopenia , both percentage value and absolute counts, and increased percentage of NK cells were found in uremic patients(P〈0. 005). The HD patients showed decreased B lymphocyte (4.33 ± 1.69% Vs 9.49±3.30% P=0. 001) and increased percentage of monocyte (75.6 ± 9.68% VS 63.98 ± 12.82% P = 0.039) compared with those without receiving HD therarpy. The number of leukocyte and the percentage of CD3^+, CD4^+, and CD8^+ showed no significant changes among uremic patients and control group. The Th1/Th2 ratio was decreased markedly in uremic patients (P〈0.05).Conclusions Uremic patients showed Th2 predominance. Lymphopenia and Thl/Th2 imbalance may contribute to the immuno-insufficiency in HD patients.
机构地区 北京医院肾内科
出处 《中国血液净化》 2006年第5期248-251,共4页 Chinese Journal of Blood Purification
关键词 尿毒症 淋巴细胞减少症 B淋巴细胞 TH1细胞 TH2细胞 流式细胞术 Uremia Lymphopenia B lymphocyte Th1 cell Th2 cell Flowcytometry
  • 相关文献

参考文献18

  • 1Tolkoff-RubinNE,Rubin RH.Uremia and host defenses.N Engl J Med,1990,322:770-772
  • 2Descamps-latscha B,Jungers P.New molecular aspects of chronic uremia and dialysis-related immunocompetent cell activation.Nephrol Dial Transplant,1996,11(suppl 2):s121-s124
  • 3Kaneko T,Osono E,Hayama N,et al.T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.Clin Nephrol,1997,48:353-358
  • 4Griveas I,Visvardis G,Papadopoulou D,et al.Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis.Ren Fail,2005,27:275-278
  • 5Griveas I,Visvardis G,Fleva A,et al.Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.Ren Fail,2005,27:279-82
  • 6Gema FF,Maria AR,Mariaconsuelo GP,et al.B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2.Nephrol Dial Transplant,2000,15:502-510
  • 7Yoshihiro D,Satonori K,Shousuke S.Characteristic cytokine production of Th1 and Th2 cells in hemodialysis patients.Nephron,1999,83:237-245
  • 8Matsumoto Y.Abnormalities of cellular immunity in uremic patients.Jpn J Nephrol,1993,35:733-742
  • 9Raska KJ,Raskova J,Shia SM,et al.T cell subsets and cellular immunity in end stage renal disease.Am J Med,1993,75:734-740
  • 10Nishimoto.A,Matsumoto Y.Increase of peripheral natural killer T cells in hemodialysis patients.Clin Nephrol,2001,55:121-126

同被引文献88

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部